Cargando…
Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
Olodaterol (BI 1744 CL) is a novel, once-daily long-acting β(2)-agonist (LABA) designed with the aim of improving β(2)-adrenoreceptor selectivity and intrinsic activity. Phase III pivotal trials have documented that olodaterol Respimat Soft Mist inhaler 5 μg induces fast onset of bronchodilation, co...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675639/ https://www.ncbi.nlm.nih.gov/pubmed/26676161 http://dx.doi.org/10.2147/TCRM.S73581 |